News
Vamousse® head lice products now listed by top three distributors in the USA
03 March 2015
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is pleased to announce that its Vamousse head lice products are now listed by AmerisourceBergen, the second biggest distributor of pharmaceutical products in the USA, further paving the way for distribution to the large network of independent pharmacies in the USA.
This agreement follows the recently announced listings for Vamousse obtained with McKesson and Cardinal Health, the number one and number three distributors of pharmaceutical products in the USA respectively.
These listings represent an important milestone for Tyratech providing the essential first step in accessing the approximate 20,000 independent pharmacies in the USA. With combined estimated sales of more than $350 billion in 2014, these three distributors have specific programs designed to reach independent pharmacies and chains of local and regional pharmacies. The listings will now allow TyraTech to access these specific programs and progressively deploy its Vamousse products during 2015 and beyond.
Bruno Jactel, Chief Executive Officer, said: "This new listing with AmerisourceBergen marks another important step in the commercialisation of our core intellectual property and in the expansion of our distribution network for our Vamousse products. Following the recent listing of Vamousse Protection Shampoo at Walmart and the addition of Lloyds and Day Lewis in the UK, we are delighted to have added the three biggest distributors to independent pharmacies in the USA, giving us an important route into the 20,000 independent pharmacies in the USA. The team at TyraTech is very excited by the growth opportunities presented by the continually expanding distribution network for Vamousse products."
Further information on Vamousse™ is available on the Company's website at www.vamousselice.com
For further information please contact:
| TyraTech Inc. Bruno Jactel, Chief Executive Officer Vincent Morgus, Chief Financial Officer and Treasurer |
Tel: +1 919 415 4340 Tel: +1-919-415-4287 |
| SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44 203 368 3551 |
| Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: 44 20 3328 5656 |
| Whitman Howard Limited, Joint Broker Ranald McGregor-Smith/ Niall Devins |
Tel: 44 20 7087 4550 |
| Walbrook, Financial PR and IR Nick Rome/ Guy McDougall |
Tel: +44 20 7933 8792 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.